Skip to main content
Premium Trial:

Request an Annual Quote

Cellectis, Two Blades Ink TALEN Technology Cross-licensing Deal

NEW YORK (GenomeWeb) – Ag-bio organizations Cellectis Plant Sciences and the Two Blades Foundation announced that they have signed a cross-licensing agreement for their respective TAL effector nuclease gene-editing technologies.

Under the deal, Two Blades has received a license to Cellectis' TALEN technology for non-profit uses, including its efforts to support subsistence farming, as well as certain commercial applications related to its ongoing disease-resistance programs.

Cellectis has received a license to Two Blades' TAL effector code technology related to nucleases for commercial uses in certain undisclosed crop plants. Cellectis has also been granted an option to expand its license to additional crops.

Financial terms of the arrangement were not disclosed.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.